Kinaset Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Kinaset Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma (NCT07532265) | Kinaset Therapeutics Inc | 2026-07-16 |
| Single and Multiple Ascending Dose Study of KN-002 (NCT05006521) | Kinaset Therapeutics Inc | 2021-07-30 |
Track Kinaset Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.